Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - CAPITAL EXPENDITURES
Capital Expenditures KALV - KalVista Pharmaceuticals, Inc.
-443 K
LAST VALUE
31.02%
2 YEAR CAGR
16.34%
5 YEAR CAGR
-37.76%
10 YEAR CAGR